title: Opinion and evidence for treatments in endocrine disorders.
abstract: New treatments and treatment protocols for endocrine disorders are evolving rapidly, and research and development activity in the endocrinology field is high. Optimal therapy remains contentious in some areas. To help you keep up to date with the latest advances worldwide on all aspects of drug therapy and management of endocrine disorders, this section of the journal brings you information selected from the rapid drug news alerting service Inpharma WeeklyInpharma Weekly provides rapid alerts to news on drugs and drug therapy. Summarizing information selected from over 1600 biomedical journals, this newsletter is produced by Adis International Limited and is available in a variety of formats. Please contact your nearest Adis office for subscription details. The use of trade names, identified by ['~'] or the use of a registered (((R))) or trademark (trade mark) symbol, is for product identification purposes only and does not imply endorsement.. Each issue contains easy-to-read summaries of the most important research and development news, clinical studies, treatment guidelines, pharmacoeconomic and adverse drug reaction news, and expert opinion pieces published in the world's top endocrinology journals.
mesh_terms: D035843:Biomedical Research; D020811:Biomedical Technology; D004345:Drug Industry; D004358:Drug Therapy; D064420:Drug-Related Side Effects and Adverse Reactions / Q000188:drug therapy; D004700:Endocrine System Diseases / Q000188:drug therapy; D004704:Endocrinology; D006801:Humans; D014486:United States Food and Drug Administration; D014937:Work